Development and validation of an LCMS/MS method to quantify lysergic acid diethylamide (LSD), iso‐LSD, 2‐oxo‐3‐hydroxy‐LSD, and nor‐LSD and identify novel metabolites in plasma samples in a controlled clinical trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1098-2825|32|2|jcla.22265-jcla.22265

ISSN: 0887-8013

Source: Journal Of Clinical Laboratory Analysis (Electronic), Vol.32, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract